blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2252311

EP2252311 - HETEROARYL-CONTAINING TRIPEPTIDE HCV SERINE PROTEASE INHIBITORS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  13.12.2013
Database last updated on 02.11.2024
Most recent event   Tooltip13.12.2013Application deemed to be withdrawnpublished on 15.01.2014  [2014/03]
Applicant(s)For all designated states
Enanta Pharmaceuticals, Inc.
500 Arsenal Street
Watertown, MA 02472 / US
[2010/47]
Inventor(s)01 / GAI, Yonghua
13 Valley View Dr.
North Grafton MA 01536 / US
02 / OR, Yat, Sun
169 Fayette Street
Watertown MA 02472 / US
03 / WANG, Zhe
67 Westwoods Blvd.
Hockessin DE 19707 / US
 [2010/47]
Representative(s)Modiano, Micaela Nadia, et al
Modiano & Partners
Thierschstrasse 11
80538 München / DE
[N/P]
Former [2010/47]Modiano, Micaela Nadia, et al
Modiano & Partners Thierschstrasse 11
80538 München / DE
Application number, filing date09704928.222.01.2009
[2010/47]
WO2009US31679
Priority number, dateUS20080023238P24.01.2008         Original published format: US 23238 P
[2010/47]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2009094438
Date:30.07.2009
Language:EN
[2009/31]
Type: A1 Application with search report 
No.:EP2252311
Date:24.11.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 30.07.2009 takes the place of the publication of the European patent application.
[2010/47]
Search report(s)International search report - published on:US30.07.2009
ClassificationIPC:A61K38/00, A61K31/4965
[2010/47]
CPC:
A61K31/4965 (EP,US); A61K38/21 (EP,US); A61P1/16 (EP);
A61P31/12 (EP); A61P31/14 (EP); A61P43/00 (EP);
C07K14/811 (EP,US); C07K5/06034 (EP,US); C07K5/0808 (EP,US);
C07K5/1016 (EP,US); Y02A50/30 (EP,US) (-)
C-Set:
A61K31/4965, A61K2300/00 (EP,US);
A61K38/21, A61K2300/00 (US,EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/47]
TitleGerman:HETEROARYL-ENTHALTENDE TRIPEPTID HCV SERIN PROTEASE-INHIBITOREN[2010/47]
English:HETEROARYL-CONTAINING TRIPEPTIDE HCV SERINE PROTEASE INHIBITORS[2010/47]
French:INHIBITEURS DE LA SÉRINE PROTÉASE DU VHC TRIPEPTIDIQUE CONTENANT UN HÉTÉROARYLE[2010/47]
Entry into regional phase20.08.2010National basic fee paid 
20.08.2010Search fee paid 
20.08.2010Designation fee(s) paid 
20.08.2010Examination fee paid 
Examination procedure20.08.2010Amendment by applicant (claims and/or description)
20.08.2010Examination requested  [2010/47]
01.08.2013Application deemed to be withdrawn, date of legal effect  [2014/03]
09.09.2013Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2014/03]
Fees paidRenewal fee
06.01.2011Renewal fee patent year 03
09.01.2012Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
31.01.201305   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]US2007161575  (MIAO ZHENWEI [US], et al);
 [Y]US2007161789  (COTTRELL KEVIN M [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.